Kyowa Kirin Co (STU:KY4) FFO


STU:KY4 Kyowa Kirin Co Ltd STU:KY4
84 GF Score
Price €14.30
GF Value €15.89
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kyowa Kirin Co FFO?

FFO (Funds from operations) only applies to REITs.

STU:KY4
84GF Score
Kyowa Kirin Co Ltd STU:KY4
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kyowa Kirin Co (STU:KY4) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of €14.30 is trading 10% below its estimated GF Value™ of €15.89. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for STU:KY4:

  • FFO:
  • GF Value™: €15.89 vs. price of €14.30 (10% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the STU:KY4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
84GF Score

Get the complete analysis for STU:KY4

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.30
Price
€15.89
GF Value